Metabolic syndrome in Type 2 diabetes: Comparison of WHO, modified ATPIII & IDF criteria

Asma Ahmed, Talha Ehsan Khan, Tahira Yasmeen, Safia Awan, Najmul Islam

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Abstract

Objectives: To determine the frequency of metabolic syndrome in type 2 diabetes according to three commonly used operational definitions {World Health Organization(WHO), National Cholesterol Education Program Adult Treatment Panel(NCEP ATP III) and International Diabetes Federation(IDF)}. To evaluate the agreement between these classifications in the Pakistani cohort. Methods: Data was collected retrospectively of 210 patients with type 2 diabetes visiting outpatient clinics of one of the large tertiary care hospitals at Karachi, Pakistan between June 2008 to November 2008. Results: The prevalence of metabolic syndrome was found to be 81.4% (WHO), 86.7 %(IDF) and 91.9 %(NCEP ATPIII). The degree of agreement (kappa statistic) was found to be highest among IDF & NCEP ATPIII (0.728) as compared to (0.436 & 0.417) between WHO & ATP and WHO & IDF respectively. The most significant predictors for metabolic syndrome were found out to be female gender OR= 8.74 95% CI 1.51-50.53, low HDL cholesterol levels OR= 0.89 95% CI 0.84-0.94 and high systolic blood pressure OR= 1.06 95% CI 1.009-1.11. Conclusion: Our study results suggested that NCEP ATPIII and IDF are the most reliable criteria for diagnosing metabolic syndrome in type 2 diabetic patients, with NECP capturing more patients in comparison to IDF definition. The alarmingly high frequency of metabolic syndrome in type 2 diabetes found in this study suggests that primary prevention strategies should be initiated earlier and early in this ethnic group and our health care system should be geared up to cope with this deadly quartet.

Original languageEnglish
Pages (from-to)569-574
Number of pages6
JournalJournal of the Pakistan Medical Association
Volume62
Issue number8
Publication statusPublished - Jun 2012

Keywords

  • Diabetes
  • Metabolic Syndrome
  • Obesity
  • Prevalence World Health Organization

Fingerprint

Dive into the research topics of 'Metabolic syndrome in Type 2 diabetes: Comparison of WHO, modified ATPIII & IDF criteria'. Together they form a unique fingerprint.

Cite this